Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Edelris is an established French drug discovery CRO specializing in medicinal chemistry, custom synthesis, high-throughput screening, and analytical services. Its core strength lies in designing and providing access to unique natural product-inspired compound libraries—leveraging its EDEN™ platform—to accelerate early-stage drug discovery for pharmaceutical and biotech partners. The company has contributed to multiple successful collaborations with leading pharma companies such as Pfizer and innovative biotechs like Cedilla Therapeutics. It has also participated in major European initiatives like the European Lead Factory.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Edelris.